Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00418314 · ClinicalTrials.gov registry record · NA
FREEDOM - A Frequent Optimization Study Using the QuickOpt Method
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 1,647
- Enrollment target
NCT00418314 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,647 participants.
The verdict
NCT00418314, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,647 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate that frequent atrio-ventricular (AV/PV) and inter-ventricular (V-V) delay optimization using QuickOpt in patients with cardiac resynchronization therapy device results in improved clinical response over standard of care (i.e. empiric programming or one-time optimization using any non-intracardiac electrogram optimization methods).
Interventions
- DEVICE Control
- DEVICE QuickOpt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,647 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00418314
The ClinicalTrials.gov registry entry for NCT00418314 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,647 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT00418314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00418314 about?
NCT00418314 is a clinical study titled "FREEDOM - A Frequent Optimization Study Using the QuickOpt Method". The objective of this study is to demonstrate that frequent atrio-ventricular (AV/PV) and inter-ventricular (V-V) delay optimization using QuickOpt in patients with cardiac resynchronization therapy device results in improved clinical response over standard of care (i.e. empiric programming or one-t...
What is the current status of trial NCT00418314?
This trial is currently completed. It is a NA study. The enrollment target is 1,647 participants. The study started on 2006-10. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00418314?
The interventions under investigation include: Control (DEVICE), QuickOpt (DEVICE).
Who is sponsoring clinical trial NCT00418314?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.